041sek
-1,0 %
Date:2025-05-13Time:18:00:00Latest report:Q1-2025List:First NorthTicker:SCIB
Market Cap:140 msekEnterprise Value:106 msekNet Sales:32,5 msekEarnings:-77,8 msekEmployees:0ISIN:SE0007045414

Ratios

10-year key figure history for Scibase turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Scibase with index and moving average MA50 and MA200.

Stockprice:0,41
MA50:0,40
MA200:0,42
Price/MA200:-1,0 %
RSI (14):56,9
Price/MA50:3,9 %

Description

SciBase Holding is a global medical technology group specialized in diagnostics and prevention in dermatology. The company develops, produces and commercializes Nevisense, a patient-centered platform that combines AI (artificial intelligence) with EIS technology to enable early detection and intervention of skin cancer and other skin diseases. Nevisense is based on over 20 years of research at Karolinska Institutet, the headquarters are in Stockholm.

Medical Equipment